Parse Biosciences · 12 hours ago
Sales Development Representative, Central/Mountain US
Parse Biosciences is a global life sciences company focused on advancing human health and scientific research through innovative single cell sequencing technologies. They are seeking a Sales Development Representative to generate leads, engage potential customers, and support sales efforts across academic, biotech, and pharmaceutical sectors. This remote role offers a clear path for career progression and requires strong technical skills and a passion for sales.
BioinformaticsBiotechnologyGeneticsLife Science
Responsibilities
Be responsible for achieving sales objectives across a geography, developing new business, and generating potential customer leads at new accounts who have an interest in our single cell RNA sequencing products
Generate and manage a high volume of calls and zoom meetings (target of 30 calls per day)
Become an expert in using lead development software, specifically LinkedIn Navigator, Crunchbase, and SciLeads
Maintain a CRM process that include calls and conversation notes
Be skilled and consistent with research and follow-up
Effectively communicate value proposition and technical advantages to customers
Continually develop technical knowledge related to new, emerging, and related single cell research
Display a high degree of professionalism both internally and externally
Qualification
Required
A minimum of a Bachelor's in biology/genomics or a related field
Strong desire to develop a career in life science sales
Previous molecular biology lab experience
Excellent communication skills - written & verbal, including phone communication skills
Self-motivation and a strong ability to work autonomously and effectively manage tasks and goals without constant supervision
Having a home office within the Central or Mountain US Time Zones
Company
Parse Biosciences
Parse Biosciences is a biotechnology startup company that develops single-cell sequencing kit solutions for researchers.
Funding
Current Stage
Growth StageTotal Funding
$99.96MKey Investors
Soleus CapitalHorizon Technology FinanceBioeconomy Capital
2025-11-04Acquired
2023-12-14Series C· $50M
2023-12-14Debt Financing
Recent News
2026-01-22
2026-01-22
Company data provided by crunchbase